Event

In recent years there has been substantial progress in the understanding and management of non-small cell lung cancer. In this symposium we aim to illuminate all the rest of the thoracic tumors, both malignant and benign, that a care-giver in pulmonology can find. There are only limited available therapies for small cell lung cancer (SCLC) and mesothelioma, mainly below first line of therapy. Some controversies in the management of these two malignant devastating diseases will be further discussed. Knowing and understanding the advancements in imaging and diagnosis of other thoracic tumors, e.g. mediastinal masses, neuroendocrine tumors and endobronchial lesions are crucial in better understanding the real nature of a mass or tumor found. Lastly, this symposium will address state of the art management of these different pulmonary tumors, and future perspectives, enabling experts and trainees to search and develop new modalities to treat these diseases.